Funding for Global Cancer Research and Training
The Center for Global Health (CGH) funds research to reduce the global burden of cancer and offers research training opportunities for investigators to strengthen their research abilities.
Sort the table below for current funding opportunities for global cancer research and research training.
Learn more about grants and funding from the National Institutes of Health.
Current Funding Opportunities
| Title | Announcement Number | Opening Date | Due Date | Additional Resources |
|---|---|---|---|---|
| Notice of Intent to Publish a Notice of Funding Opportunity for Global Training for Research and Equity in Cancer (GlobTREC) (U2R Clinical Trial Optional) | NOT-CA-25-028 | 02/28/2025 | 07/14/2025 |
Estimated Publication Date of Notice of Funding Opportunity: February 28, 2025 First Estimated Application Due Date: July 14, 2025 |
| Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) | PAR-25-143 | 01/16/2025 | 02/16/2025 | |
| Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) | PAR-25-144 | 01/05/2025 | 02/05/2025 | |
| Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed) | PAR-25-233 | 01/16/2025 | 02/16/2025 | |
| Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional) | PAR-25-242 | 02/21/2025 | 03/21/2025 | |
| Co-infection and Cancer (R01 Clinical Trial Not Allowed) | PAR-25-082 | 01/05/2025 | 02/05/2025 | |
| Co-infection and Cancer (R21 Clinical Trial Not Allowed) | PAR-25-083 | 01/16/2025 | 02/16/2025 | |
| Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R21 Clinical Trial Not Allowed) | PAR-25-108 | 01/16/2025 | 02/16/2025 | |
| Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R01 Clinical Trial Not Allowed) | PAR-25-107 | 01/05/2025 | 02/05/2025 | |
| Implementation Research for Multi-morbidity Management in the Context of Non-communicable Diseases in Low- and Middle-Income Countries and US Tribal Populations (R01 Clinical Trial Optional) | PAR-25-213 | 01/07/2025 | 02/07/2025 | |
| Notice of Special Interest (NOSI): Career Development Opportunities for Research on Cancer in Global Settings at the Center for Global Health at the National Cancer Institute | NOT-CA-24-098 | 09/10/2024 | 10/12/2024 | This notice applies to due dates on or after October 12, 2024, and subsequent receipt dates through January 8, 2027. Applicants are strongly advised to consult the due date matrix listed in each of the relevant NOFOs before applying. |
| Administrative Supplements to Support Cancer Disparity Collaborative Research Program (Clinical Trial Option) | PAR-22-114 | 12/23/2024 | 01/23/2025 | Administrative Supplements to Support Cancer Disparity Collaborative Research - Fact Sheet |
| Notice of Special Interest (NOSI): Dissemination and Implementation Science for Cancer Prevention and Control in Low Resource Environments | NOT-CA-24-064 | 07/18/2024 | 02/05/2025 |
Interested applicants must submit applications for this initiative using one of the following Dissemination and Implementation Research in Health NOFOs:
Reissue of NOT-CA-22-038
|
| Notice of Special Interest: Health Influences of Gender as a Social and Structural Variable | NOT-OD-24-038 | 12/08/2023 | 12/20/2024 | Interested applicants with a proposal focused on research in low- and middle-income countries should contact Paul Pearlman (paul.pearlman@nih.gov) to discuss how to respond to this NOSI. |
| Notice of Special Interest (NOSI): Pragmatic Trials in Low Resource Settings | NOT-CA-23-078 | 7/27/2023 | 10/17/2024 |
This NOSI applies to application due dates on or after October 17, 2023, and subsequent receipt dates through November 18, 2025. |
Training Opportunities
Explore cancer research programs and research training offered and funded through CGH.